Many of the recent discussions about health care in the United States have been riddled with disagreements and divisiveness, but some organizations are finding common ground to achieve their goals.
Critical Path Instititute or C-Path is a Tucson-based independent, non-profit organization that was established in 2005. It came on the heels of a 2004 report by the United States Food and Drug Administration that addressed the noticeable decline in medical products being submitted for approval.
Many experts say cooperation can help solve that, and C-Path's administrators say they are working with public and private entities- such as industry and academia- to try to accomplish this.
Carolyn Compton is the president and CEO of the group. She says the present system needs attention and action.
"To get new therapies to patients it now takes about 15 years and greater than a billion dollars, some people have said that it's more in the range of $4 billion to $11 billion to get one new therapy to market. This is both ludicrous and unsustainable," Compton says.
Steve Broadbent is the chief operating officer and he says the organization joins forces with domestic and international entities. They include agencies from Japan and Europe.
"We have 41 companies, industry, largely pharmaceutical companies that have come together," Broadbent says.
"But we also work, as Compton says, with the FDA, with the National Institutes of Health and the federal government and their counterparts in other parts of the world," Broadbent adds.
Compton says C-Path is ready to begin a new chapter, phase two, that hopes to attract new partners and growth.